Journal
FEBS OPEN BIO
Volume 11, Issue 6, Pages 1607-1620Publisher
WILEY
DOI: 10.1002/2211-5463.13157
Keywords
apolipoprotein M; atherosclerosis; cholesterol; high‐ density lipoprotein; Scavenger receptor class B type I
Categories
Funding
- National Natural Science Foundation of China [81201352, 81370372]
- Natural Science Foundation of Jiangsu Province [BK2012154, BK20130244]
- Science and Technology Project of Changzhou Health Commission [WZ202003]
Ask authors/readers for more resources
This study showed that ApoM is expressed in mouse macrophages and is involved in cholesterol uptake, similar to SR-BI. ApoM-enriched HDL facilitated cholesterol efflux from macrophages, while recombinant human ApoM protein inhibited this ability.
Apolipoprotein M (ApoM) exhibits various anti-atherosclerotic functions as a component of high-density lipoprotein (HDL) particles. Scavenger receptor class B type I (SR-BI) is a classic HDL receptor that mediates selective cholesterol uptake and enhances the efflux of cellular cholesterol to HDL. However, the effect of ApoM on cholesterol transport in macrophages remains unclear. In this study, we identified for the first time that ApoM is expressed in mouse macrophages and is involved in cholesterol uptake, similar to SR-BI. NBD-cholesterol uptake and efflux in cells were characterized using fluorescence spectrophotometry. The uptake ratios of cholesterol by macrophages from ApoM(-/-)SR-BI-/- mice were significantly lower than those from ApoM(+/+)SR-BI-/- and ApoM(-/-)SR-BI+/+ mice. Real-time fluorescence quantitative PCR was used to analyze the expression of cholesterol transport-related genes involved in cholesterol uptake. ApoM-enriched HDL (ApoM(+)HDL) facilitated more cholesterol efflux from murine macrophage Ana-1 cells than ApoM-free HDL (ApoM(-)HDL). However, recombinant human ApoM protein inhibited the ability of ApoM(-)HDL to induce cholesterol efflux. In conclusion, ApoM promotes cholesterol uptake and efflux in mouse macrophages. A better understanding of ApoM function may lead to the development of novel therapeutic strategies for treating atherosclerotic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available